Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats

Toxicology Mechanisms and Methods

Volumn 21, Issue 1, 2011, Pages 13-24

  Tiwari, Dhermendra K ^a   Jin, Takashi ^b   Behari, J ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Comet assay; ED XRF; Liver function test; Nanoparticle toxicity; Silver nanoparticle (AgNP)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; BLOOD CELL COUNT; BODY WEIGHT; CONTROLLED STUDY; DNA STRAND; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ERYTHROCYTE COUNT; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GEL ELECTROPHORESIS; HEMOGLOBIN DETERMINATION; LEUKOCYTE COUNT; LIVER FUNCTION TEST; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE COUNT; WISTAR RAT;

ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; LIVER; METAL NANOPARTICLES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SILVER; SPLEEN;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 78650452336     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2010.529184     Document Type: Article

References (58)

1. Asharani P V, Hande M P, Valiyaveettil S. 2009a. Anti-proliferative activity of silver nanoparticles. BMC Cell Biology 10:65.
2. Asharani PV, Kah Mun GL, Hande MP, Valiyaveettil S. 2009b. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS-Nano 3: 279-290.
3. Asharani P V, Wu YL, Gong Z, Valiyaveettil S. 2008. Toxicity of silver nanoparti-cles in zebrafsh models. Nanotechnolgy 19:255102.
4. Baldi C, Minoia C, Di NA, Capodaglio E, Manzo L. 1988. Efects of silver in isolated rat hepatocytes. Toxicol Lett 41:261-268.
5. Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. 2009. Toxicity assessments of multisized gold and silver nanoparticles in zebrafsh embryos. Small 5:1897-1910.
6. Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH, Surprenant A, Lopez-Castejon G, Mann S, Davis SA, Hails LA, Ingham E, Verkade P, Lane J, Heesom K, Newson R, Case PC. 2009. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotech 4:876-883.
7. Bradford MM. 1976. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
8. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. 2005. In vitro cyto-toxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88:412-419.
9. Brown JS, Zeman KL, Bennett WD. 2002. Ultrafne particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240-1247.
10. Castillo PM, Herrera JL, Fernandez-Montesinos R, Caro C, Zaderenko AP, Mejias JA, Pozo D. 2008. Tiopronin monolayer-protected silver nano-particles modulate IL-6 secretion mediated by Toll-like receptor ligands. Nanomed 3:627-635.
11. Chen J, Han CM, Lin XW, Tang ZJ, Su SJ. 2006. Efect of silver nanoparticle dressing on second degree burn wound. Zhonghua Wai Ke Za Zhi 44: 50-52.
12. Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662-668.
13. Colvin VL. 2003. Te potential environmental impact of engineered nanoma-terials. Nat Biotechnol 21:1166-1170.
14. Damm C, Munstedt H. 2008. Kinetic aspects of the silver ion release from antimicrobial polyamide/silver nanocomposites. Appl Phys A 91: 479-486.
15. Dufn R, Tran L, Brown D, Stone V, Donaldson K. 2007. Proinfammogenic efects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19:849-856.
16. Gan X, Liu T, Zhong J, Liu X, Li G.2004. Efect of silver nanoparticles on the electron transfer reactivity and the catalytic activity of myoglobin. Chem Bio Chem 5:1686-1691.
17. Gogoi SK, Gopinath P, Paul A, Ramesh A, Ghosh SS, Chattopadhyay A. 2006. Green fuorescent protein expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir 22:9322-9328.
18. Gopinath P, Gogoi SK, Chattopadhyay A, Ghosh SS. 2008. Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnology 19:1-10.
19. Gopinath P, Gogoi SK, Sanpui P, Paul, A. Chattopadhyay, Arun., Ghosh SS. 2010. Signaling gene cascade in silver nanoparticle induced apoptosis. Colloid Surf B Biointerfaces 77:240-245.
20. Gwinn MR, Vallyathan V. 2006. Nanoparticles: health efects-pros and cons. Environ Health Perspect 114:1818-1825.
21. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. 2007. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mut Res 631:55-61.
22. +. Biochemistry 44:13214-13223.
23. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro tox-icity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19: 975-983.
24. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung, JH, Song KS, Yu IJ. 2007. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 19:857-871.
25. Jin CY, Zhu BS, Wang X F, Lu QH. 2008a. Cytotoxicity of titanium dioxide nano-particles in mouse fbroblast cells. Chem Res Toxicol 21:1871-1877.
26. Jin T, Fujii F, Komai Y, Seki J, Seiyama A, Yoshioka Y. 2008b. Preparation and characterizationof highly fuorescent, glutathione-coated near infrared quantum dots for in vivo fuorescence imaging. Int J Mol Sci 9: 2044-2061.
27. Jin T, Yoshioka Y, Fujii F, Komai Y, Seki J, Seiyama A. 2008c. Gd3+-functionalized near-infrared quantum dots for in vivo dual modal (fuorescence/mag-netic resonance) imaging. Chem Comm 30:5764-5766.
28. Kawata K, Osawa M, Okabe S. 2009. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43:6046-6051.
29. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY. 2007. Antimicrobial efects of silver nanoparticles. Nanomed 3:95-101.
30. Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY. 2009. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In-Vitro 23:1076-1084.
31. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575-583.
32. Kneipp J, Kneipp H, McLaughlin M, Brown D, Kneipp K. 2006. In vivo molecular probing of cellular compartments with gold nanoparticles and nanoag-gregates. Nano Lett 6:2225-2231.
33. Kulmeet KS, Catherine MM, Joseph MS, Sallie WS, Vincent MR. 2002. Gold nanoparticle-mediated transfection of mammalian cells. Bioconjugate Chem 13:3-6.
34. Liu L, Zhang J, Su X, Mason RP. 2008. In vitro and in vivo assessment of CdTe and CdHgTe toxicity and clearance. J Biomed Nanotechnol 4:524-528.
35. Loeb WF, Quimby FW, editors. 1999. Te clinical chemistry of laboratory animals. Philadelphia, PA: Taylor & Francis.
36. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM. 2006. Proteomic analysis of the mode of antibacterial action of silver nanopar-ticles. J Proteome Res 5:916-924.
37. Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627.
38. Pamela LD, Kyle JH. 2005. Exposure-related health efects of silver and silver compounds: a review. Ann Hyg 49:575-585.
39. Pandey R, Zahoor A, Sharma S, Khuller GK. 2003. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis (Edinb) 83:373-378.
40. Park JH, Gu L, Maltzahn G V, Ruoslahti E, Bhatia SN, Sailor MJ. 2009. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 8:331-336.
41. Santoro CM, Duchsherer NL, Grainger DW. 2007. Minimal in vitro antimicrobial efcacy and ocular cell toxicity from silver nanoparticles. Nanobiotech 3:55-65.
42. Schipper ML, Ratchford NN, Davis CR, Shi Kam NW, Chu P, Liu Z, Sun X, Dai H, Gambhir SS. 2008. A pilot toxicology study of single-walled carbon nano-tubes in a small sample of mice. Nat Nanotechnol 3:216-221.
43. Shin SH, Ye MK, Kim HS, Kang HS. 2007. Te efects of nanosilver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 7:1813-1818.
44. Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. 2009. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 6:1357-1364.
45. Simon-Deckers A, Gouget B, Mayne-L'hermite M, Herlin-Boime N, Reynaud C, Carrière M. 2008. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneu-mocytes. Toxicology 253:137-146.
46. Singh AV, Patil R, Kasture MB, Gade WN, Prasad BL. 2009. Synthesis of Ag-Pt alloy nanoparticles in aqueous bovine serum albumin foam and their cytocompatibility against human gingival fbroblasts. Colloid Surf B Biointerfaces 69:239-245.
47. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Contr Rel 70:1-20.
48. Sukdeb P, Yu KT, Joon MS. 2007. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712-1720.
49. Sun Y, Xia Y. 2002. Shape-controlled synthesis of gold and silver nanoparticles. Science 298:2176-2179.
50. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ, Yu IJ. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452-461.
51. Sung JJ, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Kim J, Kim TS, Chang HK, Lee EJ,Lee JH,Yu, IJ. 2008. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nano-particle. Inhal Toxicol 20:567-574.
52. Susan WP, Wijnhoven JGM, Peijnenburg CAH, Werner IH, Agnes GO, Evelyn HWH, Boris R, Julia B, Ilse G, Dik VM, Susan D, Wim HDJ, Maaike Z, Adriënne JAM, Robert EG. 2009. Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2:109-138.
53. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafne silver particles in rats. Environ H Perspect 109:547-551.
54. Tiwari DK, Behari J, Sen P. 2008. Time and dose dependent antimicrobial potential of Ag-nanoparticle synthesized by top-down approach. Curr Sci 95:1-10.
55. Wissing SA, Kayser O, Muller RH. 2004. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257-1272.
56. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Mark RW, Nel AE. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794-1807.
57. +-poly(gammaglutamic acid)-silver nitrate complex via chemical reduction process. Colloid Surf B Biointerfaces 59:171-178.
58. Zolghadri S, Saboury AA, Golestani A, Divsalar A, Rezaei-Zarchi S, Moosavi-Movahedi AA. 2009. Interaction between silver nanoparticle and bovine hemoglobin at diferent temperatures. J Nanoparticle Res 11: 1751-1758.